NCI10495
OPEN TO ACCRUAL
PH1 Study of DS-8201a in Combination with Neratinib in Solid Tumors with HER2 Alterations
UW21125
OPEN TO ACCRUAL
Ph 1 Study of GS-1811 alone and with Anti-PD-1 Monoclonal Antibody in Advanced Solid Tumors
UW23126
OPEN TO ACCRUAL
A Phase 1a/1b Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
UW23151
OPEN TO ACCRUAL
Ph 1 Study of SynKIR-110, CAR-T Therapy in Pts w/ MSLN-Expressing OC, CCA, or Mesothelioma